We are live on ! Find out more
MRNY icon

YieldMax MRNA Option Income Strategy ETF

4 hedge funds and large institutions have $12M invested in YieldMax MRNA Option Income Strategy ETF in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

163% more capital invested

Capital invested by funds: $4.57M → $12M (+$7.43M)

2.27% more ownership

Funds ownership: 1.98%4.25% (+2.3%)

0% more funds holding

Funds holding: 44 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

Holders
4
Holders Change
Holders Change %
0%
% of All Funds
0.06%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
3
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

MRNY Hedge Fund Activity: Q2 2024 in Review

4 of the 6,931 institutional investors tracked by Wall St. Rank reported a position in YieldMax MRNA Option Income Strategy ETF (MRNY) for Q2 2024, worth a combined $12M — up 163% from $4.57M a quarter earlier.

Fund positioning in MRNY was balanced in Q2 2024: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 0 trimmed.

The largest buyer was Tidal Investments, adding an estimated $10.6M. The largest seller was Plante Moran Financial Advisors, exiting entirely with an estimated $10.5K sold.

  • 4 institutional investors held YieldMax MRNA Option Income Strategy ETF (MRNY) as of Q2 2024, unchanged from Q1 2024.
  • Funds reported $12M of YieldMax MRNA Option Income Strategy ETF stock for Q2 2024, up 163% quarter-over-quarter.
  • 1 fund opened new YieldMax MRNA Option Income Strategy ETF positions in Q2 2024 and 1 closed out, a net change of 0 holders.
  • The largest YieldMax MRNA Option Income Strategy ETF buyer in Q2 2024 was Tidal Investments, an estimated $10.6M added.
  • The largest YieldMax MRNA Option Income Strategy ETF seller in Q2 2024 was Plante Moran Financial Advisors, an estimated $10.5K sold.

Based on aggregated 13F filings for Q2 2024.